Acute myeloid leukemia, disease (disorder)
AML 15 Clinical Trial Collection
Year Started: 2002
Samples from the AML 15 Clinical Trial
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
-
Other animal work restriction, Xenograft restriction
| Associated Data Type |
Procurement Timeframe |
| Clinical records |
3 - 6 months |
| Followup records |
3 - 6 months |
| Treatment records |
3 - 6 months |
Female
Young adult (18 - 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Liquid nitrogen vapor phase |
|
Not applicable |
75% -99% |
| Primary cells |
|
Liquid nitrogen vapor phase |
|
Not applicable |
11 - 25% |
Male
Young adult (18 - 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Liquid nitrogen vapor phase |
|
Not applicable |
51 - 75% |
| Primary cells |
|
Liquid nitrogen vapor phase |
|
Not applicable |
51 - 75% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Liquid nitrogen vapor phase |
|
Not applicable |
75% -99% |
| Primary cells |
|
Liquid nitrogen vapor phase |
|
Not applicable |
26 - 50% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Liquid nitrogen vapor phase |
|
Not applicable |
75% -99% |
| Primary cells |
|
Liquid nitrogen vapor phase |
|
Not applicable |
11 - 25% |